Britannica
Sources used in this answer
Why is multidrug-resistant tuberculosis harder to cure than drug-sensitive tuberculosis?
Created from Britannica articles
using AI.
AI can make mistakes, so verify using Britannica articles.
tuberculosis
A doctor examining chest X-rays of patients infected with tuberculosis, which remains one of the world's deadliest diseases.
Multidrug-resistant tuberculosis (MDR-TB) is significantly harder to cure than drug-sensitive tuberculosis because the causative bacilli have developed resistance to the most effective first-line medications, specifically isoniazid and rifampicin.12
Because the infection does not respond to these standard antibiotics, treatment becomes substantially more complex and difficult. Key factors contributing to the challenge include:3
- Treatment Duration: While drug-sensitive TB is typically treated over a period of months, curing MDR-TB often requires a rigorous treatment regimen lasting up to two years.13
- Medication Toxicity: The alternative drugs required to treat resistant strains are often less effective and associated with more severe side effects than standard therapies.13
- Adherence Challenges: The extended duration and complexity of the required drug regimens make it difficult for patients to maintain consistent adherence, which is essential for a successful cure.3
Incomplete or improper treatment remains a primary driver of this resistance, as it allows surviving bacilli to multiply and develop further resistance to multiple agents.12